Welcome to Med-Kolleg - Health in Germany

This Health-Provider-Directory is designed to help doctors and other users to find out information on all aspects of the German health market.
We also refer international travelers requiring medical assistance to qualified doctors or specialists.

Med Kolleg is a health portal with general medicine and health topics. We have search facilities that allows you to find a hospital / clinic or practitioner in Germany from our database (physicians in Germany / hospitals in Germany). Med-Kolleg is completely independent from German insurances, hospitals and doctors.

Please note that general medical information - as provided on this website - does not replace visiting a physician or a medical emergency service, only a physician can assess the individual situation of your health.

2010-02-03:
Daiichi Sankyo initiates largest single, double - blind, randomized, Phase III trial for treatment and prevention of recurrent venous thromboembolism
Tokyo, Japan and Edison, N.J. ( na Originaltextservice ) - First Patient Randomized and Dosed in New Trial with Factor Xa Inhibitor, Edoxaban Daiichi Sankyo Company, Limited ( TSE: 4568 ), announced today that it has initiated a new large - scale pivotal Phase III trial for edoxaban, (...) Read more...

2010-02-01:
First Treatment to Improve Survival in 20 Years
Osaka, Japan and London ( PRN/ots ) - Takeda Pharmaceutical Company Limited ( "Takeda" ) and Takeda Pharmaceuticals Europe Limited ( "TPEU" ), its wholly owned subsidiary for oversight of pan - European sales and marketing, jointly announced today that Mepact( R ) ( mifamurtide )( 1 ), the first new treatment in 20 years to improve survival (...) Read more...

2010-02-01:
Cephalon, Inc. Announces Agreement to Acquire Mepha AG
FRAZER, Philadelphia, AESCH, Switzerland and MAISONS ALFORT, France, February 1 ( PRN/ots ) - - Cephalon, Inc. announced today that it has signed an agreement to acquire Mepha AG and its subsidiaries, a profitable, privately - held, Swiss - based pharmaceutical company. Mepha has specific expertise in innovative dosage (...) Read more...

2010-01-25:
AMP Supports the Creation of a National Immunization Technical Advisory Group in Côte d'Ivoire
Paris ( PRN/ots ) - On January 15, the Minister of Health and Hygiene of Côte d'Ivoire, Dr. Rémi Allah Kouadio, presided over a ceremony to mark the launch of a National Immunization Technical Advisory Group ( NITAG ) named "Côte d'Ivoire National Committee of Independent Experts for (...) Read more...

2010-01-21:
Abbott to Suspend Marketing of Obesity Medicine Sibutramine in European Union Countries
Abbott Park, Illinois ( PRN/ots ) - Today the Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMA ) voted to recommend the suspension of marketing authorizations for all anti - obesity medicines containing sibutramine. Abbott will comply with the CHMP recommendation and (...) Read more...

2010-01-21:
New Real World Avastin Data From Over 3,200 Metastatic Colorectal Cancer Patients Confirms Survival Benefit Beyond 2 Years
Basel, Switzerland ( PRN/ots ) - New data from two large studies observing the routine use of Avastin - based therapy in more than 3,200 patients will be announced showing impressive treatment benefits in a non - selected patient population. Key findings included high rates of tumour shrinkage (...) Read more...

2010-01-14:
Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
Abbott Park, Illinois ( PRN/ots ) - A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe. This simple blood test is expected to help in the assessment (...) Read more...

2010-01-07:
Tolerx Completes Enrollment in DEFEND - 1, A Phase 3 Type 1 Diabetes Study With Otelixizumab
Cambridge, Massachusetts ( PRN/ots ) - Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND - 1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new - onset autoimmune type 1 diabetes. (...) Read more...

2010-01-06:
New Abbott Gene - Based Test for Colorectal Cancer Receives CE Mark
Des Plaines, Illinois ( PRN/ots ) - Abbott announced today it has received CE Marking ( Conformite Europeene ) in the European Union for a new molecular diagnostic test, Abbott RealTime mS9 Colorectal Cancer, a non - invasive DNA assay that detects the methylated form of Septin 9, a (...) Read more...

2010-01-05:
New Analysis Showed Efient( R ) Cost - Effective Compared with Clopidogrel for Patients with Acute Coronary Syndromes Undergoing PCI
Tokyo and Indianapolis ( PRN/ots ) - Results from a health economic substudy of the TRITON - TIMI 38 clinical trial showed that among patients with acute coronary syndrome ( ACS ) managed with percutaneous coronary intervention ( PCI ), including stenting, treatment with Efient( R ) ( prasugrel ) compared with branded clopidogrel ( Plavix( R ) ) was (...) Read more...

1 2 3 4 5 6 7 8 9 10 11 more...

Surveys / Reports

Notifiable Disease Surveillance and Practicing Physicians
Primary care physicians in Germany are essential participants in infectious disease surveillance through mandatory reporting.
In 2001, a new infectious disease control law (IfSG) was implemented in Germany. Most diseases are to be reported to the local county (Landkreis) health department from where they are reported by the state (Land) to the national surveillance institute (Robert Koch Institute). The IfSG also introduced national case definitions for notifiable diseases. The aim of this study was to identify the needs and attitudes of primary care physicians towards public health surveillance.
These issues were investigated in a questionnaire survey among 8,550 randomly sampled physicians in Germany in 2001.
» Krause G, Ropers G, Stark K. Notifiable disease surveillance and practicing physicians. Emerg Infect Dis [serial on the Internet]. 2005 Mar

Hospitals: latest entries / changes:

3331 entries in clinics directory.

DocSearch: latest entries / changes:

Dentist Search: latest entries / changes: